Clock gene influences on sleep quality and HPA axis in major depressive disorder

dc.contributor.authorFerrer, Alex
dc.contributor.authorPelegrí, Ariadna
dc.contributor.authorLabad, Javier
dc.contributor.authorSagues, Teresa
dc.contributor.authorSalvat-Pujol, Neus
dc.contributor.authorDe Arriba Arnau, Aida
dc.contributor.authorM. Menchón, José
dc.contributor.authorPalao, Diego
dc.contributor.authorCostas, Javier
dc.contributor.authorCarracedo, Angel
dc.contributor.authorSoria, Virginia
dc.date.accessioned2026-02-19T09:57:02Z
dc.date.available2026-02-19T09:57:02Z
dc.date.issued2025-12-17
dc.date.updated2026-02-09T10:39:35Z
dc.description.abstractBackground: Major Depressive Disorder (MDD) has been associated with disruptions in circadian rhythms and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. Circadian rhythms are regulated by clock genes, including BMAL1, which are also implicated in HPA axis function. This study aimed to examine the association between BMAL1 polymorphisms and sleep quality, their interactions with sex and MDD diagnosis, and their potential influence on HPA axis activity in MDD. Methods: The sample included 84 patients with MDD and 120 healthy controls (HCs). Clinical and sociodemographic variables were assessed. HPA axis activity was measured using the cortisol awakening response (CAR) and diurnal cortisol slope. Six single nucleotide polymorphisms (SNPs) in the BMAL1 gene were analyzed. Multiple regression models were used, adjusting for relevant covariates. Results: The BMAL1 SNP rs11022778 was significantly associated with sleep quality in the total sample. Interaction analyses revealed that this association was specific to individuals with MDD. Additionally, rs11022778 was significantly associated with both CAR and slope measures among MDD patients. Conclusions: These findings highlight the potential role of BMAL1 gene variants in modulating biological and clinical phenotypes related to circadian and stress regulation. The rs11022778 variant may contribute to altered sleep quality and HPA axis activity in MDD. Future research should consider such genetic markers to inform more personalized approaches to MDD treatment.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid41429085
dc.identifier.urihttps://hdl.handle.net/2445/227056
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.sleep.2025.108730
dc.relation.ispartofSleep Medicine, 2025, vol. 139, p. 108730
dc.relation.urihttps://doi.org/10.1016/j.sleep.2025.108730
dc.rightscc by (c) Ferrer, Alex, et al, 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.classificationTrastorns del soncat
dc.subject.classificationFisiologia del soncat
dc.subject.classificationSíndromes d'apnea del soncat
dc.subject.otherSleep disorderseng
dc.subject.otherSleep physiologyeng
dc.subject.otherSleep apnea syndromeseng
dc.titleClock gene influences on sleep quality and HPA axis in major depressive disorder
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S1389945725024050-main.pdf
Mida:
686.12 KB
Format:
Adobe Portable Document Format